Abstract
IntroductionAutologous haematopoietic stem cell transplantation (aHSCT) is increasingly used as treatment for patients with active multiple sclerosis (MS), typically after failure of disease-modifying therapies (DMTs). A recent phase III trial,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have